Shares of Arena Pharmaceuticals slid 3.03% to $76.07 at 12:36 EST on Tuesday, after five successive sessions in a row of gains. NASDAQ Composite is dropping 0.37% to $12,851.27, after two successive sessions in a row of gains. This seems, as yet, a somewhat rough trend trading session today.

Arena Pharmaceuticals’s last close was $78.45, 18.56% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Volatility

Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 0.47%, 1.62%, and 0.87%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 2.07%, 3.59%, and 3.20%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $76.07 at 12:36 EST, way under its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s worth is above its 50-day moving average of $69.42 and higher than its 200-day moving average of $70.02.

LEAVE A REPLY

Please enter your comment!
Please enter your name here